Scynexis Newsroom

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and SCYNEXIS (SCYX)

TipRanksNov 12 00:22

Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 9 01:32

SCYNEXIS's Strong Financial Position and Strategic Advancements Drive Buy Rating

TipRanksNov 9 00:48

Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Maintains Target Price $8

Futu NewsAug 13 19:33

Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Maintains Target Price $8

Futu NewsJul 25 03:32

Promising Clinical and Financial Prospects for SCYNEXIS: A Comprehensive Buy Rating Analysis

TipRanksJul 25 03:22

Buy Rating Affirmed for Scynexis on Robust Financials and Promising Antifungal Pipeline

TipRanksMay 11 00:20

Analysts' Top Healthcare Picks: Cormedix (CRMD), SCYNEXIS (SCYX)

TipRanksMay 11 00:15

Buy Rating Affirmed for SCYNEXIS on Strong Financials and Promising Pipeline Prospects

TipRanksApr 11 23:20

Buy Rating Affirmed for SCYNEXIS on Ibrexafungerp Success and Strong GSK Partnership

TipRanksApr 2 18:51

SCYNEXIS Analyst Ratings

BenzingaApr 1 20:35

Promising Antifungal Drug Developments Bolster Buy Rating for SCYNEXIS

TipRanksJan 31 20:05

Analysts Have Conflicting Sentiments on These Healthcare Companies: SCYNEXIS (SCYX) and Kymera Therapeutics (KYMR)

TipRanksJan 3 20:01

Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Ocuphire Pharma (OCUP)

TipRanksSep 29, 2023 02:40

Ladenburg Thalmann Cuts SCYNEXIS Price Target to $7.50 From $15, Maintains Buy Rating

MT NewswiresSep 25, 2023 23:26

SCYNEXIS (SCYX) Receives a Buy From Ladenburg Thalmann & Co.

TipRanksSep 25, 2023 23:15

SCYNEXIS (SCYX) Receives a Buy From Maxim Group

TipRanksAug 16, 2023 23:35

Cantor Fitzgerald Reiterates Overweight on SCYNEXIS, Maintains $15 Price Target

BenzingaAug 15, 2023 22:29

SCYNEXIS Analyst Ratings

BenzingaAug 15, 2023 22:28

SCYNEXIS (SCYX) Receives a Buy From Ladenburg Thalmann & Co.

TipRanksAug 15, 2023 19:05